Structured evidence table for Nac Respiratory Infections Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Nac Respiratory Infections Meta-Analysis | CONCLUSION: Erdosteine 900 mg is most effective for improving lung function and reducing oxidative stress, while cineole is safer with a lower incidence of adverse reaction and acute exacerbation. | 1 | Zhao Y (2026) | Efficacy and safety of mucolytic agents in patients with chronic obstructive pulmonary disease: a systematic review and network meta-analysis. |
| Nac Respiratory Infections Meta-Analysis | BACKGROUND: This study aimed to compare the efficacy and safety of different mucolytic agents in patients with COPD. | 1 | Zhao Y (2026) | Efficacy and safety of mucolytic agents in patients with chronic obstructive pulmonary disease: a systematic review and network meta-analysis. |
| Nac Respiratory Infections Meta-Analysis | The control groups received placebo, usual care, or a medication other than the intervention group. | 1 | Zhao Y (2026) | Efficacy and safety of mucolytic agents in patients with chronic obstructive pulmonary disease: a systematic review and network meta-analysis. |
| Nac Respiratory Infections Meta-Analysis | Despite robust evidence, NAC remains underutilized; greater clinical integration requires clearer guideline recommendations and clinician awareness. | 2 | Barne Monica (2026) | N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) |
| Nac Respiratory Infections Meta-Analysis | This review consolidates current evidence and expert consensus on NAC for clinical reference. | 2 | Barne Monica (2026) | N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) |
| Nac Respiratory Infections Meta-Analysis | This reduces mucus viscosity and facilitates improved mucociliary clearance.Anti-inflammatory effect of NAC: NAC modulates NF-κB signaling and scavenges reactive oxygen species (ROS), reducing inflammatory activation. | 2 | Barne Monica (2026) | N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) |
| Nac Respiratory Infections Meta-Analysis | 1 2 Figure 1 3 4 5 6 7 12 N-acetylcysteine (NAC), an acetylated derivative of L-cysteine, serves as a precursor of glutathione (GSH), a key pulmonary antioxidant. | 2 | Barne Monica (2026) | N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) |
Source documents